Review
doi: 10.1016/j.jelectrocard.2003.11.003.
Drug-induced cardiac toxicity: emphasizing the role of electrocardiography in clinical research and drug development
Affiliations
- PMID: 15132365
- DOI: 10.1016/j.jelectrocard.2003.11.003
Item in Clipboard
Review
Drug-induced cardiac toxicity: emphasizing the role of electrocardiography in clinical research and drug development
J Electrocardiol.
2004 Jan.
Abstract
This review describes the role of electrocardiography in clinical research and drug development, and addresses its utility in defining cardiac toxicity from noncardiac investigational drugs. Principles for designing electrocardiographic monitoring for cardiac safety in clinical trials are also reviewed.
Similar articles
-
A definitive or thorough phase 1 QT ECG trial as a requirement for drug safety assessment.J Electrocardiol. 2004 Jan;37(1):25-9. doi: 10.1016/j.jelectrocard.2003.11.004. J Electrocardiol. 2004. PMID: 15132366 Review.
-
Tyrosine kinase inhibitor (TKI)-induced cardiotoxicity: approaches to narrow the gaps between preclinical safety evaluation and clinical outcome.J Appl Toxicol. 2012 Dec;32(12):945-51. doi: 10.1002/jat.2813. Epub 2012 Sep 10. J Appl Toxicol. 2012. PMID: 22961481 Review.
-
Can business and science coexist in this century?J Ark Med Soc. 2001 Jun;97(12):401. J Ark Med Soc. 2001. PMID: 11383496 No abstract available.
-
Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead.Drug Saf. 2005;28(11):1009-28. doi: 10.2165/00002018-200528110-00003. Drug Saf. 2005. PMID: 16231954 Review.
-
Drug-induced liver injury: Hy's rule revisited.Clin Pharmacol Ther. 2006 Jun;79(6):521-8. doi: 10.1016/j.clpt.2006.02.012. Clin Pharmacol Ther. 2006. PMID: 16765139 Review. No abstract available.
Cited by
-
How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?Br J Pharmacol. 2011 Jun;163(4):675-93. doi: 10.1111/j.1476-5381.2011.01255.x. Br J Pharmacol. 2011. PMID: 21306581 Free PMC article. Review.
-
Effect of trabectedin on the QT interval in patients with advanced solid tumor malignancies.Cancer Chemother Pharmacol. 2012 Feb;69(2):341-50. doi: 10.1007/s00280-011-1697-6. Epub 2011 Jul 8. Cancer Chemother Pharmacol. 2012. PMID: 21739119 Free PMC article. Clinical Trial.
-
Effects of echinocandin preparations on adult rat ventricular cardiomyocytes. Preliminary results of an in vitro study.Anaesthesist. 2014 Feb;63(2):129-34. doi: 10.1007/s00101-014-2289-8. Epub 2014 Feb 7. Anaesthesist. 2014. PMID: 24499961 Free PMC article.
-
Magnitude, mechanism, and reproducibility of QT interval differences between superimposed global and individual lead ECG complexes.Ann Noninvasive Electrocardiol. 2007 Apr;12(2):145-52. doi: 10.1111/j.1542-474X.2007.00153.x. Ann Noninvasive Electrocardiol. 2007. PMID: 17593183 Free PMC article.
-
Cardiac effects of echinocandins after central venous administration in adult rats.Antimicrob Agents Chemother. 2015 Mar;59(3):1612-9. doi: 10.1128/AAC.04446-14. Epub 2014 Dec 29. Antimicrob Agents Chemother. 2015. PMID: 25547351 Free PMC article.